[Value of Déanxit in the ambulatory treatment of depressive states. Clinical study of 205 cases].
D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D000873:Anthracenes / Q000008:administration & dosage / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010044:Outpatient Clinics, Hospital; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014966:Xanthenes / Q000008:administration & dosage / Q000627:therapeutic use
D000873:Anthracenes; D004338:Drug Combinations; D010879:Piperazines; D014149:Tranquilizing Agents; D014966:Xanthenes
Intérêt du Déanxit dans le traitement ambulatoire des états dépressifs. Etude relative à 205 cas cliniques.